Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy

Pierre G. Coulie(de Duve Institute), Benoı̂t J. Van den Eynde(de Duve Institute), Pierre van der Bruggen(de Duve Institute), Thierry Boon(Ludwig Cancer Research)

Nature reviews. Cancer

January 24, 2014

10.1038/nrc3670

Cited by 1,115

Abstract

Related Papers

Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

K. T. Brunner, Jacques Mauël, J C Cerottini et al.|PubMed|1968|1.4k

Intradermal Immunization of C3H Mice against a Sarcoma That Originated in an Animal of the Same Line

Ludwik Gross|Cancer Research|1943|363

HLA class I-restricted lysis of leukemia cells by a CD8+ cytotoxic T-lymphocyte clone specific for WT1 peptide

Hideki Ohminami, Masaki Yasukawa, Shigeru Fujita|Blood|2000|344

MHC Ligands and Peptide Motifs

Hans‐Georg Rammensee, Jutta Bachmann, Stefan Stevanović|Molecular biology intelligence unit|1997|332

Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells.

David Boczkowski, Smita K. Nair, Jiyoung Nam et al.|PubMed|2000|312